These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34065544)

  • 1. Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery.
    Boisguérin P; Konate K; Josse E; Vivès E; Deshayes S
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34065544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment.
    Gaspar R; Coelho F; Silva BFB
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery.
    Tagalakis AD; Maeshima R; Yu-Wai-Man C; Meng J; Syed F; Wu LP; Aldossary AM; McCarthy D; Moghimi SM; Hart SL
    Acta Biomater; 2017 Mar; 51():351-362. PubMed ID: 28110069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide/Lipid-Associated Nucleic Acids (PLANAs) as a Multicomponent siRNA Delivery System.
    Hall R; Alasmari A; Mozaffari S; Mahdipoor P; Parang K; Montazeri Aliabadi H
    Mol Pharm; 2021 Mar; 18(3):986-1002. PubMed ID: 33496597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles.
    Margus H; Arukuusk P; Langel Ü; Pooga M
    Mol Pharm; 2016 Jan; 13(1):172-9. PubMed ID: 26561739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes.
    Lo JH; Kwon EJ; Zhang AQ; Singhal P; Bhatia SN
    Bioconjug Chem; 2016 Oct; 27(10):2323-2331. PubMed ID: 27583545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.
    Trabulo S; Cardoso AL; Mano M; De Lima MC
    Pharmaceuticals (Basel); 2010 Mar; 3(4):961-993. PubMed ID: 27713284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics.
    Ewert KK; Scodeller P; Simón-Gracia L; Steffes VM; Wonder EA; Teesalu T; Safinya CR
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-Based Nanoparticle Functionalization with Coiled-Coil Peptides for
    Aschmann D; Knol RA; Kros A
    Acc Chem Res; 2024 Apr; 57(8):1098-1110. PubMed ID: 38530194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the internalization mechanism of WRAP:siRNA nanoparticles.
    Deshayes S; Konate K; Dussot M; Chavey B; Vaissière A; Van TNN; Aldrian G; Padari K; Pooga M; Vivès E; Boisguérin P
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183252. PubMed ID: 32135145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Penetrating Peptides as Vehicles for Delivery of Therapeutic Nucleic Acids. Mechanisms and Application in Medicine.
    Timotievich ED; Shilovskiy IP; Khaitov MR
    Biochemistry (Mosc); 2023 Nov; 88(11):1800-1817. PubMed ID: 38105200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery.
    Qin Y; Walters AA; Rouatbi N; Wang JT; Abdel-Bar HM; Al-Jamal KT
    Biomaterials; 2023 Aug; 299():122158. PubMed ID: 37243988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing an Optimal Solvent Is Crucial for Obtaining Cell-Penetrating Peptide Nanoparticles with Desired Properties and High Activity in Nucleic Acid Delivery.
    Biswas A; Maloverjan M; Padari K; Abroi A; Rätsep M; Wärmländer SKTS; Jarvet J; Gräslund A; Kisand V; Lõhmus R; Pooga M
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in peptide-based nucleic acid delivery.
    Veldhoen S; Laufer SD; Restle T
    Int J Mol Sci; 2008 Jun; 9(7):1276-1320. PubMed ID: 19325804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of Stable and Homogeneous Cell-Penetrating Peptide NF55 Nanoparticles for Efficient Gene Delivery In Vivo.
    Freimann K; Arukuusk P; Kurrikoff K; Pärnaste L; Raid R; Piirsoo A; Pooga M; Langel Ü
    Mol Ther Nucleic Acids; 2018 Mar; 10():28-35. PubMed ID: 29499941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-based nanoparticle for ex vivo and in vivo drug delivery.
    Crombez L; Morris MC; Deshayes S; Heitz F; Divita G
    Curr Pharm Des; 2008; 14(34):3656-65. PubMed ID: 19075741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalisation and Biological Activity of Nucleic Acids Delivering Cell-Penetrating Peptide Nanoparticles Is Controlled by the Biomolecular Corona.
    Lorents A; Maloverjan M; Padari K; Pooga M
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways.
    Dowaidar M
    Mitochondrion; 2024 Sep; 78():101906. PubMed ID: 38797356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Penetrating Peptides for the Lungs.
    Kumari A; Pal S; G BR; Mohny FP; Gupta N; Miglani C; Pattnaik B; Pal A; Ganguli M
    Mol Pharm; 2022 May; 19(5):1309-1324. PubMed ID: 35333535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.